Private equity IDD providers now include some of the largest companies serving people with intellectual and developmental disabilities in the United States. If you own an IDD provider, there’s a good chance a private equity-backed buyer has already approached you, or will. Some owners see that as their best exit. Others won’t consider it.
Both reactions deserve better information. This guide explains how private equity actually works in IDD, what these buyers pay for, why the model attracts real scrutiny, and how to vet a private equity buyer if you decide to talk to one. It supports our main guide to who buys IDD services companies.
Key takeaways
- Private equity firms acquired more than 1,000 disability and elder care providers between 2013 and 2023, according to the Private Equity Stakeholder Project.
- PE buyers form platforms, then grow them with add-on acquisitions, usually planning to sell within several years.
- Scrutiny is rising. Regulators and advocates have raised concerns about staffing and quality, and Illinois enacted HB4728 in 2026 to add oversight of PE ownership in IDD (PESP).
- If you sell to private equity, vet the buyer’s track record, fund timeline and staffing commitments as carefully as they vet you.
How does private equity invest in IDD providers?
Private equity firms raise funds from investors, buy companies, try to grow them and sell them later, usually within several years. In IDD, a firm typically buys a larger provider as a platform, then adds smaller providers as add-ons to build scale, expand into new states and add service lines, before selling the combined business.
That cycle shapes everything about how a PE buyer behaves. They care about growth, systems that can absorb acquisitions, and a management team that can run a bigger business. They also have a clock. A fund that bought its platform five years ago is thinking about its exit, which affects how it values your business and what it will ask of you after closing.
How big is private equity in IDD services?
Large and growing. The Private Equity Stakeholder Project’s March 2025 report counted over 1,000 private equity acquisitions of disability and elder care providers from 2013 to 2023, and estimated that the ten largest PE-owned companies in its analysis employ roughly 313,400 workers. Its list includes home care companies alongside IDD specialists.
Some of the best-known names are PE-backed. Sevita, which operates brands including The Mentor Network and REM, is owned by Centerbridge Partners and Vistria Group, according to the PESP report. Stateline reported that Sevita operates in 40 states and draws 85% to 90% of its revenue from Medicaid.
The biggest recent deal shows the scale. In January 2026 the FTC required Sevita to divest 128 intermediate care facilities before completing its $835 million purchase of BrightSpring’s ResCare Community Living business.
Why does private equity want IDD providers?
Because demand is steady and needs-based, the market is fragmented and the sector has held up through economic cycles. The Braff Group counted a record 31 IDD transactions in 2025 and noted that IDD deal flow kept pace with pre-pandemic levels through 2022 and 2023, when most sectors slowed.
Demand is also far larger than supply. KFF found more than 600,000 people on Medicaid home and community-based services waiting lists in 2025, about 74% of them with I/DD. And the market is made up of many small, often single-state providers, which is exactly what a buy-and-build strategy needs. As Kevin Taggart put it in Mertz Taggart’s Q2 2026 report, “ABA and I/DD are still where the most consistent buyer interest is.”
What criticism do private equity IDD providers face?
Advocates and regulators have raised concerns about staffing levels, training, quality of care and debt-funded payouts at some PE-owned providers. The Private Equity Stakeholder Project documented problems including understaffing and inadequate training at several companies. States have responded with more oversight, including a 2026 Illinois law targeting PE ownership in IDD.
Owners considering a PE buyer should understand these concerns rather than dismiss them. PESP reported that Centerbridge and Vistria collected about $475 million in debt-funded dividends from Sevita and Help at Home, and Stateline described how states struggle to oversee large national operators with many brand names. The FTC, in its Sevita action, said competition between providers had been critical to ensuring they compete on quality and choice.
None of this means every PE buyer is a bad partner. Many invest in systems, training and wages that smaller providers can’t afford. It does mean you should look closely at the specific buyer, its track record and what it commits to in writing about your staff and the people you support.
7 things to know before selling to private equity IDD providers
1. They usually pay the most, for the right business
PE platforms pay the highest multiples in IDD. HealthFMV reported larger IDD platforms with more than $5 million of EBITDA trading at 6x to 10x EBITDA. Add-on buyers pay less per dollar but can still compete strongly. See our guide to IDD valuation multiples for how platform and add-on pricing differ.
2. Part of the price may come later
PE offers often include rollover equity, where you reinvest part of your proceeds in the buyer’s company, and sometimes earnouts. Compare offers on cash at closing first, then weigh the rest as upside with risk.
3. Rollover equity can pay well, or not at all
If the platform grows and sells for more, your stake can be worth a lot. If it struggles or carries heavy debt, it may be worth little. Ask how much debt sits ahead of your equity and when the fund expects to sell.
4. The fund has a timeline
Ask when the fund was raised and when it expects to exit. A buyer early in its hold period plans differently from one preparing to sell next year.
5. You’ll likely stay for a while
Many PE buyers want the owner or key managers to stay through a transition period, sometimes a year or more. Get clear on your role, authority, pay and exit terms before you sign.
6. Integration will change things
Add-on buyers fold you into their systems, policies and often their brand. Ask what happens to your name, your managers, wages and benefits.
7. Competition is what protects you
A single PE buyer sets the terms. Several competing buyers, including strategic and nonprofit alternatives, reveal your business’s real value. Our guide on how to sell an IDD business explains how to run that process.
What does a sale to private equity IDD providers look like, step by step?
It runs in seven stages, from an NDA and a non-binding indication of interest through management meetings, a letter of intent, outside diligence, the purchase agreement and closing. The process is more structured than a sale to a local operator and moves on the buyer’s investment committee schedule, so knowing the stages helps you keep control of the timeline.
- Introduction and NDA. The buyer signs a confidentiality agreement before seeing detailed information.
- Indication of interest. A non-binding price range, based on your summary financials.
- Management meeting and site visits. The buyer’s team meets you and your managers, usually at a discreet time.
- Letter of intent. Price, structure, rollover, earnout, working capital and a period of exclusivity.
- Confirmatory diligence. Quality of earnings, legal, billing, licensing, staffing and real estate reviews, often by outside firms.
- Purchase agreement and approvals. Lawyers negotiate terms while change-of-ownership filings go to the state.
- Closing and integration. Most buyers start an integration plan in the first months after closing.
Private equity IDD providers are experienced at this, and you should be too. The letter of intent is where you have the most bargaining power, so resolve the big terms there, not after exclusivity starts.
How do you vet a private equity buyer?
Ask about the fund’s age and exit timeline, how much debt the platform carries, how prior acquisitions have performed, what happened to staff and wages at companies they’ve bought, and their survey and compliance record. Then speak with owners who sold to them before. A good buyer answers these questions easily.
Useful checks include:
- References from former owners. Ask what changed after closing and whether promises were kept.
- Survey and inspection records. State reports on the platform’s existing facilities are often public.
- News and regulatory history. Search the platform’s brand names, not just the parent company.
- Written commitments. Put staffing, wage and name commitments in the purchase agreement or side letters where possible.
- Debt levels. Especially if you’re taking rollover equity.
Is private equity the right buyer for you?
It can be, if you want the strongest price, you’re open to rollover equity and a few years of working with new owners, and the specific buyer has a good record. It may not be, if continuity of mission and culture matters more to you than the last dollar. In that case, compare offers from nonprofit systems and regional operators too.
The best answer comes from comparing real offers, not assumptions. For how consolidation is reshaping the buyer market, read our guide to IDD market consolidation. And if rollover equity is on the table, see our guide to IDD deal structures.
Frequently asked questions
Is private equity buying IDD providers?
Yes. Private equity firms have been active buyers of IDD providers for years, forming platforms and adding smaller providers as add-ons. The Private Equity Stakeholder Project counted more than 1,000 PE acquisitions of disability and elder care providers between 2013 and 2023, and IDD deal volume reached a record 31 transactions in 2025.
Do private equity IDD providers pay more than other buyers?
Often, yes, especially for larger providers that can become platforms, where HealthFMV reported multiples of 6x to 10x EBITDA. But part of a PE offer may come as rollover equity or an earnout, so compare cash at closing. Strategic and nonprofit buyers sometimes offer terms that suit certain owners better.
What happens to staff when a private equity firm buys an IDD provider?
Most buyers want to keep direct support staff, because replacing them is costly. Changes more often hit administrative roles as the provider is folded into the buyer’s systems. Ask each buyer directly about wages, benefits and roles, check what happened at their past acquisitions, and put commitments in writing.
Why is private equity in IDD controversial?
Advocates and some regulators have raised concerns about understaffing, training, quality of care and debt-funded payouts at certain PE-owned providers, and about how hard it is for states to oversee large national operators. Some states are responding with new oversight, such as Illinois’s 2026 law on PE ownership in IDD.
How do I know if a private equity buyer is a good fit?
Check the fund’s timeline and debt levels, its record on staffing and compliance at past acquisitions, and speak with owners who sold to it. Compare its offer with strategic and nonprofit alternatives. A good fit is a buyer whose plans for your staff and the people you support match your own priorities.
Can I sell only part of my IDD business to private equity?
Yes. A majority recapitalization lets you sell a controlling stake and keep a minority share, so you share in the upside when the buyer sells again. It suits owners who want liquidity now but believe in the growth plan. Understand the governance terms and debt levels first.
Private equity IDD providers: the bottom line
Private equity IDD providers can offer strong prices and resources, and they come with timelines, integration and real public scrutiny. Go in with clear eyes: vet the specific buyer, compare cash at closing, understand any rollover equity, and put staffing commitments in writing. Then let competition decide.
| Been approached by a private equity buyer? Get the IDD Exit Report newsletter for quarterly buyer updates, or book a confidential conversation with the IDD team at Olympic M&A before you respond. Disclosure: IDD Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm. |
